Table 5.
Adverse events (SS)
| Adverse events | Fosaprepitant group (n = 328) | Aprepitant group (n = 317) | p value |
|---|---|---|---|
| Constipation | 11 (3.35) | 10 (3.15) | 1.0000 |
| Diarrhoea | 1 (0.30) | 0 (0) | 1.0000 |
| Distension | 1 (0.30) | 0 (0) | 1.0000 |
| Headache | 1 (0.30) | 0 (0) | 1.0000 |
| Anaphylaxis | 0 (0.00) | 1 (0.32) | .4915 |
| Hiccup | 2 (0.61) | 2 (0.63) | 1.0000 |
| Laboratory test and ECG examination | |||
| White cell count | 2 (0.61) | 1 (0.32) | 1.000 |
| ALT increasing | 1 (0.30) | 0 (0.00) | 1.0000 |
| QT interval prolongation | 0 (0.00) | 2 (0.63) | .2412 |
SS, safety set.
Values are expressed as n (%).